Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
Saved in:
Main Authors: | Patricia Zhao, BS (Author), Corina A. Rusu, MD (Author), Olivia L. Schenck, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
by: Kathrin Hanfstingl, et al.
Published: (2018) -
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
by: Ya‐ting Liu, et al.
Published: (2023) -
Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient
by: Allison Kranyak, MD, et al.
Published: (2022) -
Refractory pityriasis rubra pilaris treated with upadacitinib
by: Eingun James Song, MD, et al.
Published: (2023) -
Pityriasis rubra pilaris in skin of color
by: John G. Plante, BS, et al.
Published: (2021)